| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA5197665
Max Phase: Preclinical
Molecular Formula: C19H23N3O3
Molecular Weight: 341.41
Associated Items:
Representations
Canonical SMILES: c1cc2c(cn1)Oc1ccc3cc1N2CCCCNCCOCCO3
Standard InChI: InChI=1S/C19H23N3O3/c1-2-9-22-16-5-7-21-14-19(16)25-18-4-3-15(13-17(18)22)24-12-11-23-10-8-20-6-1/h3-5,7,13-14,20H,1-2,6,8-12H2
Standard InChI Key: JGBRDJCVMLCISF-UHFFFAOYSA-N
Associated Targets(Human)
Serine/threonine-protein kinase PIM1 9629 Activities
MDA-MB-231 73002 Activities
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 341.41 | Molecular Weight (Monoisotopic): 341.1739 | AlogP: 3.10 | #Rotatable Bonds: 0 |
| Polar Surface Area: 55.85 | Molecular Species: BASE | HBA: 6 | HBD: 1 |
| #RO5 Violations: 0 | HBA (Lipinski): 6 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 0 |
| CX Acidic pKa: | CX Basic pKa: 9.91 | CX LogP: 1.78 | CX LogD: -0.89 |
| Aromatic Rings: 2 | Heavy Atoms: 25 | QED Weighted: 0.79 | Np Likeness Score: -0.43 |
References
| 1. Xu J, Shen C, Xie Y, Qiu B, Ren X, Zhou Y, Li G, Zheng G, Huang N.. (2022) Design, synthesis, and bioactivity evaluation of macrocyclic benzo[b]pyrido[4,3-e][1,4]oxazine derivatives as novel Pim-1 kinase inhibitors., 72 [PMID:35779826] [10.1016/j.bmcl.2022.128874] |
Source
Source(1):